The global benign prostatic hyperplasia (BPH) prostate treatment market is projected to grow from USD 33.03 billion in 2024 to USD 47.05 billion by 2034, registering a CAGR of 3.6% over the forecast period. This steady growth is driven by the increasing prevalence of BPH among the aging male population, rising awareness about prostate health, and advancements in minimally invasive treatment options.
With age being a major risk factor, the expanding geriatric population is significantly contributing to market demand. According to health statistics, men aged 50 and above are more likely to experience symptoms of BPH, leading to increased demand for medications, minimally invasive procedures, and surgical interventions. Additionally, the growing adoption of laser-based therapies and the advancement of transurethral resection techniques are further driving market growth.
Pharmaceutical advancements, including the development of combination drug therapies and improved alpha-blockers, are enhancing patient outcomes and increasing treatment uptake. Moreover, the rising trend of early diagnosis and proactive management of BPH is expected to support market expansion.
Request a Sample of this Report Now: https://www.futuremarketinsights.com/report-sample#5245502d47422d31363634
Key Takeaways:
- The BPH prostate treatment market is forecasted to grow at a CAGR of 3.6%, reaching USD 47.05 billion by 2034.
- Growth is driven by the aging male population and increasing awareness about prostate health.
- The market is benefiting from advancements in minimally invasive procedures and laser-based therapies.
- Pharmaceutical developments such as combination drug therapies are enhancing patient outcomes.
- North America is expected to lead the market due to high healthcare standards and a growing geriatric population.
Market Growth Factors:
- Rising prevalence of BPH due to aging demographics globally.
- Increased adoption of advanced treatment options, such as laser therapies and minimally invasive surgeries.
- Growing awareness of the condition and the availability of effective treatment modalities.
The market’s steady growth highlights the ongoing efforts by healthcare providers and manufacturers to address the unmet needs in managing BPH, improving patient outcomes, and enhancing quality of life.
Market Dynamics:
-
- Treatment Preferences: Drugs are anticipated to dominate the treatment segment, accounting for about 65.2% of the market share in 2024.
- Distribution Channels: Institutional sales are expected to represent approximately 64.7% of the market share for distribution channels.
- Growth Drivers:
- The increasing geriatric population is a significant factor contributing to market growth, as BPH is more prevalent among older men.
- Advances in treatment options, including both pharmacological and minimally invasive procedures, are enhancing patient outcomes and driving demand.
Access the Full Report : https://www.futuremarketinsights.com/reports/benign-prostatic-hyperplasia-bph-and-prostate-treatment-market
Key Companies in the Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market
- Pfizer Inc.
- NxThera Inc.
- NeoTract Inc.
- Sanofi S.A
- GlaxoSmithKline Plc.
- Allergan Plc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Eli Lily & Company
- Cardinal Health Inc.
Key Segments
By Treatment Type:
- BPH Drugs
- Alpha Blockers
- 5-Alpha Reductase Inhibitors
- Phosphodiesterase-5 (PDE-5) Inhibitors
- Muscarinic Receptor Antagonist (MRA)
- Combination Drug
- BPH Devices
- Prostatic Stents
- Suture Base Implant Systems
- Transurethral RF Thermal Therapy Devices
By Distribution Channel:
- Institutional Sales
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centres in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
